Ginkgo Bioworks Turned Its Lab Over to GPT-5
They claim that protein synthesis costs fell 40% after 36,000 automated experiments
Pharma
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 12
Highmark Is Hiring for AI Scale Amid Utilization Pressure
Job postings reveal how AI is being embedded across claims, data, and workflows
Leadership move
Pfizer Names Jeremy Forman Chief AI, Data & Analytics Officer
My focus will be on how we integrate AI and data excellence across our entire enterprise to drive value, speed, and better outcomes for the millions of people we serve"
After Google Exit, Fitbit Founders Build Family Health AI with Luffu
Luffu shifts health tech from individual trackers to shared family hubs where AI proactively monitors vitals, meds, and sleep patterns.
HCA Healthcare’s AI Projects Don’t Stop at Pilots
How centralized management turns pilots into production systems
How Beckman Coulter Life Sciences Is Preparing Lab Data for AI
The company is wiring its instruments into orchestrated workflows designed for repeatable research
Eli Lilly Plans $3.5 Billion Pennsylvania Plant for New Obesity Drug
"We're finding these medicines are quite popular, but we still have work to do to expand access, to improve affordability"
Oracle's Life Sciences AI Platform Could Cut Clinical Trial Costs by Millions
"Fragmented, inconsistent data is a major barrier to progress, holding back life sciences organizations from delivering the medical breakthroughs that could transform and even save lives"
Research
BullFrog AI Publishes White Paper on Data Harmonization for AI in Life Sciences
"The true value of AI and machine learning becomes tangible and repeatable with the harmonization of data"
Jefferson Health Is Using AI to Buy Back Clinician Time
The health system is using governed AI to cut administrative work across 23,000 clinicians.
Microsoft and Bristol Myers Squibb Deploy AI to Detect Lung Cancer Earlier
"This is a clear win for both patients and providers"
Bristol Myers Squibb Reinforces Its Research Stack
Two partnerships announced in one week span AI analysis and R&D
Intuitive.ai and Matilda Cloud Partner to Address Life Sciences' Hidden AI Infrastructure Costs
“Matilda Cloud continuously maps applications, infrastructure, and dependencies in a way that supports compliance, modernization, and operational decision-making"
OpenAI Backed Chai Discovery Partners With Eli Lilly to Accelerate Biologics Discovery
"By combining Chai’s generative design models with Lilly’s deep biologics expertise and proprietary data, the companies intend to push the frontier of how AI can design better molecules from the outset"
AstraZeneca Acquires Modella AI to Speed Up Oncology Drug Research
"Integrating our foundation models directly into AstraZeneca's research ecosystem will help translate methodological advances into real-world impact faster."
Nvidia and Eli Lilly Launch $1B AI Drug Discovery Lab
"Combining Lilly's volumes of data and scientific knowledge with Nvidia's computational power could reinvent drug discovery as we know it"
Schrödinger Partners with Eli Lilly to Democratize AI Drug Discovery
TuneLab integration gives LiveDesign users Lilly-trained safety predictions
AI Scribes Edge Closer to the Healthcare Mainstream
Until recently confined to elite health systems, ambient documentation tools are now being adopted by operators like LifePoint Health
How Eli Lilly Is Securing Its Position in the $150B Obesity Market
Lilly's strategy isn't to compete on a single drug, it's to own the computational platform that discovers tomorrow's obesity treatments.
Providence St. Joseph Hospital Lets AI Read Mammograms
Radiologists in Orange County are using FDA-cleared software to assist breast cancer screening, with humans still making the final call